MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
112.66
-4.67 (-3.98%)
At close: 4:00PM EST

112.86 +0.20 (0.18%)
After hours: 5:01PM EST

Stock chart is not supported by your current browser
Previous Close117.33
Open114.23
Bid112.51 x 900
Ask112.90 x 1100
Day's Range111.95 - 115.00
52 Week Range82.77 - 122.15
Volume11,875,011
Avg. Volume4,407,070
Market Cap151.007B
Beta (5Y Monthly)0.57
PE Ratio (TTM)32.00
EPS (TTM)3.52
Earnings DateFeb 17, 2020
Forward Dividend & Yield2.16 (1.84%)
Ex-Dividend DateDec 25, 2019
1y Target Est126.43
  • This Medtech Giant Is Grappling To Stay In A Buy Zone On Mixed Earnings
    Investor's Business Daily

    This Medtech Giant Is Grappling To Stay In A Buy Zone On Mixed Earnings

    Shares of Medtronic stock grappled to stay in a buy zone Tuesday after the medical technology company issued a "noisy" fiscal third-quarter earnings report, according to one analyst.

  • Tandem Diabetes Hits New 52-Week High: What's Driving It?
    Zacks

    Tandem Diabetes Hits New 52-Week High: What's Driving It?

    Tandem Diabetes (TNDM) is optimistic about maintaining growth momentum on several recent developments.

  • The list of insurers covering Senseonics’ diabetes device is growing. The latest? Cigna.
    American City Business Journals

    The list of insurers covering Senseonics’ diabetes device is growing. The latest? Cigna.

    Cigna is one of a handful of private payers now covering the local company's product, which measures glucose levels for diabetes patients.

  • Medtronic (MDT) Q3 Earnings Top Estimates, Revenues Miss
    Zacks

    Medtronic (MDT) Q3 Earnings Top Estimates, Revenues Miss

    Medtronic (MDT) demonstrates better-than-expected Q3 performances at CER, backed by growth in all major business segments and geographies.

  • Medtronic tops profit target but says coronavirus could impact Q4 results
    American City Business Journals

    Medtronic tops profit target but says coronavirus could impact Q4 results

    Medtronic on Tuesday warned that the fourth quarter could be hurt by a slowdown caused by the COVID-19 virus that has sickened tens of thousands in China and elsewhere.

  • MarketWatch

    Medtronic's stock falls after profit beats but sales comes up shy

    Shares of Medtronic PLC fell 1.4% in premarket trading Tuesday, after the Dublin-based medical technology company reported a fiscal third-quarter profit that beat expectations but revenue that missed. Net income rose to $1.92 billion, or $1.42 a share, from $1.27 billion, or 94 cents a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share came to $1.44, above the FactSet consensus of $1.38. Sales grew 2.3% to $7.72 billion, below the FactSet consensus of $7.81 billion, as the company's cardiac and vascular and minimally invasive therapies segments missed expectations, the restorative therapies sales were in line and the diabetes segment sales topped expectations. The company raised its full-year EPS guidance range to $5.63 to $5.65 from $5.57 to $5.63. The stock has gained 5.5% over the past three months through Friday, while the SPDR Health Care Select Sector ETF has tacked on 7.0% and the S&P 500 has advanced 8.3%.

  • GlobeNewswire

    Medtronic Reports Third Quarter Financial Results

    Revenue of $7.7 Billion Increased 2.3% Reported and 2.6% Organic GAAP Diluted EPS of $1.42 Increased 51%; Non-GAAP Diluted EPS of $1.44 Increased 12% Cash Flow from Operations.

  • Medtronic Stock Falls 3%
    Investing.com

    Medtronic Stock Falls 3%

    Investing.com - Medtronic (NYSE:MDT) Stock fell by 3.01% to trade at $113.77 by 09:40 (14:40 GMT) on Tuesday on the NYSE exchange.

  • Medtronic Earnings Beat, Revenue Misses In Q3
    Investing.com

    Medtronic Earnings Beat, Revenue Misses In Q3

    Investing.com - Medtronic reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

  • Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out
    Investor's Business Daily

    Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out

    Futures: Walmart, Medtronic and InMode earnings are due Tuesday. IPO stocks InMode, Progyny, Ping are near buy points. So is Taiwan Semiconductor. Buffett-boosted RH is likely to break out.

  • Has Medtronic (MDT) Outpaced Other Medical Stocks This Year?
    Zacks

    Has Medtronic (MDT) Outpaced Other Medical Stocks This Year?

    Is (MDT) Outperforming Other Medical Stocks This Year?

  • Medtronic Buys Digital Surgery, Boosts AI-Focus Surgical Care
    Zacks

    Medtronic Buys Digital Surgery, Boosts AI-Focus Surgical Care

    Medtronic (MDT) to integrate Digital Surgery's business within its Surgical Robotics arm, in turn augmenting the company's position in the field of surgical AI.

  • Benzinga

    The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions

    Editor's note: This story has been updated to reflect the FDA's approval Friday of Agile Therapeutics' hormonal contraceptive patch Twirla.  Biotech stocks were quiet in the week ending Feb. 14 amid some ...

  • Not one S&P 500 CEO is donating to Bernie Sanders or Elizabeth Warren
    MarketWatch

    Not one S&P 500 CEO is donating to Bernie Sanders or Elizabeth Warren

    While the moderate 2020 Democrats finished behind Bernie Sanders in New Hampshire, presidential hopefuls Amy Klobuchar, Pete Buttigieg and Joe Biden are winning over S&P 500 CEOs, as the execs vote for them with their wallets.

  • Medtronic buys British surgical AI company called Digital Surgery
    American City Business Journals

    Medtronic buys British surgical AI company called Digital Surgery

    London-based Digital Surgery has 130 employees and makes an AI technology that identifies steps in a surgery and which tools are needed for that surgery.

  • MarketWatch

    Medtronic recalls some insulin pumps

    Shares of Medtronic PLC were up 0.36% in trading on Thursday. The Food and Drug Administration said Wednesday that Medtronic had issued a recall of its MiniMed 600 Series Insulin Pumps after reports of 2,175 injuries and one death. The regulator said it is the most serious type of recall. A missing piece can cause incorrect dosing, which can lead to hypoglycemia or hyperglycemia in the Type 1 diabetes patients who use the device. Medtronic first notified affected patients of the recall in November. Medtronic's stock has gained 29% over the past year, while the S&P 500 is up 23%.

  • Medtronic recalling some MiniMed insulin pumps
    American City Business Journals

    Medtronic recalling some MiniMed insulin pumps

    Medtronic's "artificial pancreas" is the subject of a recall notice after it was discovered that a part of the device can be damaged, causing the device to malfunction. The FDA declared the recall of Medtronic's MiniMed 600 series insulin pumps a Class I recall on Wednesday, its most serious classification. Medtronic is aware of 2,175 possible injuries due to device malfunction, as well as one possible death.

  • GlobeNewswire

    Medtronic to Advance Solutions and Capabilities in Surgical Data and Analytics with Acquisition of Digital Surgery

    DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) --  Medtronic plc (MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. The acquisition of Digital Surgery will strengthen the Medtronic robotic assisted surgery platform and has applicability for the Medtronic broader portfolio. “Capabilities and solutions in the data and analytics space play a critical role in our continued focus on advancing minimally invasive surgery – from education and training, to clinical decision support, to reducing cost and unwarranted variability,” said Megan Rosengarten, vice president and general manager of the Surgical Robotics business, which is part of the Minimally Invasive Therapies Group at Medtronic.

  • Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More
    Zacks

    Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More

    Strong foothold in the emerging markets so far widely contributes to some of the industry players' Q4 results.

  • Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks

    Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth

    Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Medtronic (MDT) to Report Q3 Earnings: What's in Store?
    Zacks

    Medtronic (MDT) to Report Q3 Earnings: What's in Store?

    In the fiscal third quarter, Medtronic (MDT) is expected to have registered strong growth for TAVR across the United States, courtesy of its higher adoption by the low-risk patient population.

  • GlobeNewswire

    Medtronic and the Medtronic Foundation Commit More Than $1M to Coronavirus Efforts

    DUBLIN, Feb. 10, 2020 (GLOBE NEWSWIRE) --  Medtronic plc (MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to coronavirus relief efforts across the globe.

  • Georgia Tech alum pledges $18M, new Tech Square tower to be named for him
    American City Business Journals

    Georgia Tech alum pledges $18M, new Tech Square tower to be named for him

    The Board of Regents of the University System of Georgia on Feb. 11 approved the naming of one of the towers being constructed as part of Phase III of Tech Square in honor of William W. "Bill" George and his wife Penny George.

  • Not Finding ETFs In Buy Areas? Here's One That Beats The S&P 500
    Investor's Business Daily

    Not Finding ETFs In Buy Areas? Here's One That Beats The S&P 500

    Few funds in IBD's ETF Leaders screen are in buy areas, but iShares U.S. Medical Devices is one of the exceptions, and it's been a good investment in the long run as well.